nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2D6—Temsirolimus—kidney cancer	0.0693	0.11	CbGbCtD
Tranylcypromine—CYP3A4—Everolimus—kidney cancer	0.0652	0.104	CbGbCtD
Tranylcypromine—CYP1A2—Pazopanib—kidney cancer	0.0442	0.0702	CbGbCtD
Tranylcypromine—CYP3A4—Temsirolimus—kidney cancer	0.044	0.0701	CbGbCtD
Tranylcypromine—CYP2C9—Capecitabine—kidney cancer	0.0415	0.066	CbGbCtD
Tranylcypromine—CYP2D6—Pazopanib—kidney cancer	0.0364	0.0579	CbGbCtD
Tranylcypromine—CYP1A2—Erlotinib—kidney cancer	0.0315	0.0501	CbGbCtD
Tranylcypromine—CYP2C19—Sorafenib—kidney cancer	0.0278	0.0442	CbGbCtD
Tranylcypromine—CYP2C9—Paclitaxel—kidney cancer	0.026	0.0413	CbGbCtD
Tranylcypromine—CYP2D6—Erlotinib—kidney cancer	0.026	0.0413	CbGbCtD
Tranylcypromine—CYP1A2—Sorafenib—kidney cancer	0.0256	0.0408	CbGbCtD
Tranylcypromine—CYP3A4—Pazopanib—kidney cancer	0.0231	0.0368	CbGbCtD
Tranylcypromine—CYP2C9—Sorafenib—kidney cancer	0.0231	0.0367	CbGbCtD
Tranylcypromine—CYP2D6—Sorafenib—kidney cancer	0.0211	0.0336	CbGbCtD
Tranylcypromine—CYP2D6—Vinblastine—kidney cancer	0.0208	0.0332	CbGbCtD
Tranylcypromine—CYP3A4—Erlotinib—kidney cancer	0.0165	0.0263	CbGbCtD
Tranylcypromine—CYP3A4—Paclitaxel—kidney cancer	0.0151	0.024	CbGbCtD
Tranylcypromine—CYP3A4—Sorafenib—kidney cancer	0.0134	0.0214	CbGbCtD
Tranylcypromine—CYP3A4—Vinblastine—kidney cancer	0.0133	0.0211	CbGbCtD
Tranylcypromine—CYP3A4—Vincristine—kidney cancer	0.013	0.0207	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—kidney cancer	0.0128	0.0204	CbGbCtD
Tranylcypromine—CYP3A4—Sunitinib—kidney cancer	0.0109	0.0173	CbGbCtD
Tranylcypromine—CYP3A4—Doxorubicin—kidney cancer	0.00815	0.013	CbGbCtD
Tranylcypromine—CYP2C19—urine—kidney cancer	0.00538	0.117	CbGeAlD
Tranylcypromine—CYP1A2—urine—kidney cancer	0.0044	0.0957	CbGeAlD
Tranylcypromine—CYP2C9—urine—kidney cancer	0.00417	0.0908	CbGeAlD
Tranylcypromine—CYP2E1—urine—kidney cancer	0.00396	0.0861	CbGeAlD
Tranylcypromine—CYP3A4—urine—kidney cancer	0.00318	0.0692	CbGeAlD
Tranylcypromine—CYP2D6—urine—kidney cancer	0.00313	0.0681	CbGeAlD
Tranylcypromine—MAOB—nephron tubule—kidney cancer	0.00166	0.0362	CbGeAlD
Tranylcypromine—MAOB—renal system—kidney cancer	0.00151	0.0329	CbGeAlD
Tranylcypromine—MAOB—kidney—kidney cancer	0.00146	0.0318	CbGeAlD
Tranylcypromine—MAOB—cortex of kidney—kidney cancer	0.00142	0.031	CbGeAlD
Tranylcypromine—MAOA—nephron tubule—kidney cancer	0.00142	0.0309	CbGeAlD
Tranylcypromine—MAOB—cardiac atrium—kidney cancer	0.00135	0.0294	CbGeAlD
Tranylcypromine—MAOA—renal system—kidney cancer	0.00129	0.0281	CbGeAlD
Tranylcypromine—MAOA—kidney—kidney cancer	0.00125	0.0271	CbGeAlD
Tranylcypromine—MAOA—cortex of kidney—kidney cancer	0.00121	0.0264	CbGeAlD
Tranylcypromine—MAOA—cardiac atrium—kidney cancer	0.00115	0.0251	CbGeAlD
Tranylcypromine—CYP1A2—renal system—kidney cancer	0.00108	0.0234	CbGeAlD
Tranylcypromine—CYP2E1—nephron tubule—kidney cancer	0.00106	0.0232	CbGeAlD
Tranylcypromine—CYP2E1—renal system—kidney cancer	0.000968	0.0211	CbGeAlD
Tranylcypromine—CYP2E1—kidney—kidney cancer	0.000936	0.0204	CbGeAlD
Tranylcypromine—CYP2E1—cortex of kidney—kidney cancer	0.000911	0.0198	CbGeAlD
Tranylcypromine—CYP3A4—renal system—kidney cancer	0.000779	0.0169	CbGeAlD
Tranylcypromine—CYP2D6—renal system—kidney cancer	0.000766	0.0167	CbGeAlD
Tranylcypromine—CYP3A4—kidney—kidney cancer	0.000753	0.0164	CbGeAlD
Tranylcypromine—CYP2D6—kidney—kidney cancer	0.000741	0.0161	CbGeAlD
Tranylcypromine—Anorexia—Dactinomycin—kidney cancer	0.000398	0.00166	CcSEcCtD
Tranylcypromine—Nausea—Pazopanib—kidney cancer	0.000397	0.00166	CcSEcCtD
Tranylcypromine—Paraesthesia—Sunitinib—kidney cancer	0.000396	0.00165	CcSEcCtD
Tranylcypromine—Hypertension—Vincristine—kidney cancer	0.000395	0.00165	CcSEcCtD
Tranylcypromine—Constipation—Sorafenib—kidney cancer	0.000392	0.00164	CcSEcCtD
Tranylcypromine—Pain—Sorafenib—kidney cancer	0.000392	0.00164	CcSEcCtD
Tranylcypromine—Tinnitus—Paclitaxel—kidney cancer	0.000389	0.00162	CcSEcCtD
Tranylcypromine—Leukopenia—Gemcitabine—kidney cancer	0.000388	0.00162	CcSEcCtD
Tranylcypromine—Flushing—Paclitaxel—kidney cancer	0.000387	0.00162	CcSEcCtD
Tranylcypromine—Decreased appetite—Sunitinib—kidney cancer	0.000383	0.0016	CcSEcCtD
Tranylcypromine—Asthenia—Vinblastine—kidney cancer	0.00038	0.00159	CcSEcCtD
Tranylcypromine—Asthenia—Everolimus—kidney cancer	0.000379	0.00158	CcSEcCtD
Tranylcypromine—Constipation—Sunitinib—kidney cancer	0.000377	0.00158	CcSEcCtD
Tranylcypromine—Pain—Sunitinib—kidney cancer	0.000377	0.00158	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000375	0.00157	CcSEcCtD
Tranylcypromine—Hypertension—Gemcitabine—kidney cancer	0.000374	0.00156	CcSEcCtD
Tranylcypromine—Chills—Paclitaxel—kidney cancer	0.000374	0.00156	CcSEcCtD
Tranylcypromine—Oedema—Vincristine—kidney cancer	0.000373	0.00156	CcSEcCtD
Tranylcypromine—Alopecia—Paclitaxel—kidney cancer	0.000368	0.00154	CcSEcCtD
Tranylcypromine—Asthenia—Erlotinib—kidney cancer	0.000366	0.00153	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Vincristine—kidney cancer	0.000365	0.00153	CcSEcCtD
Tranylcypromine—Urticaria—Sorafenib—kidney cancer	0.000364	0.00152	CcSEcCtD
Tranylcypromine—Decreased appetite—Dactinomycin—kidney cancer	0.000363	0.00152	CcSEcCtD
Tranylcypromine—Diarrhoea—Vinblastine—kidney cancer	0.000363	0.00152	CcSEcCtD
Tranylcypromine—Abdominal pain—Sorafenib—kidney cancer	0.000362	0.00151	CcSEcCtD
Tranylcypromine—Body temperature increased—Sorafenib—kidney cancer	0.000362	0.00151	CcSEcCtD
Tranylcypromine—Diarrhoea—Everolimus—kidney cancer	0.000361	0.00151	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000361	0.00151	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Vincristine—kidney cancer	0.000361	0.00151	CcSEcCtD
Tranylcypromine—Pain—Dactinomycin—kidney cancer	0.000357	0.00149	CcSEcCtD
Tranylcypromine—Agranulocytosis—Capecitabine—kidney cancer	0.000356	0.00149	CcSEcCtD
Tranylcypromine—Anorexia—Vincristine—kidney cancer	0.000356	0.00149	CcSEcCtD
Tranylcypromine—Oedema—Gemcitabine—kidney cancer	0.000354	0.00148	CcSEcCtD
Tranylcypromine—Dizziness—Vinblastine—kidney cancer	0.00035	0.00146	CcSEcCtD
Tranylcypromine—Dizziness—Everolimus—kidney cancer	0.000349	0.00146	CcSEcCtD
Tranylcypromine—Muscle spasms—Paclitaxel—kidney cancer	0.000349	0.00146	CcSEcCtD
Tranylcypromine—Body temperature increased—Sunitinib—kidney cancer	0.000349	0.00146	CcSEcCtD
Tranylcypromine—Abdominal pain—Sunitinib—kidney cancer	0.000349	0.00146	CcSEcCtD
Tranylcypromine—Diarrhoea—Erlotinib—kidney cancer	0.000349	0.00146	CcSEcCtD
Tranylcypromine—Hypotension—Vincristine—kidney cancer	0.000349	0.00146	CcSEcCtD
Tranylcypromine—Bradycardia—Capecitabine—kidney cancer	0.000348	0.00146	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000346	0.00145	CcSEcCtD
Tranylcypromine—Feeling abnormal—Dactinomycin—kidney cancer	0.000344	0.00144	CcSEcCtD
Tranylcypromine—Haemoglobin—Capecitabine—kidney cancer	0.000344	0.00144	CcSEcCtD
Tranylcypromine—Haemorrhage—Capecitabine—kidney cancer	0.000342	0.00143	CcSEcCtD
Tranylcypromine—Hepatitis—Capecitabine—kidney cancer	0.000342	0.00143	CcSEcCtD
Tranylcypromine—Vision blurred—Paclitaxel—kidney cancer	0.000342	0.00143	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000342	0.00143	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000341	0.00143	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Capecitabine—kidney cancer	0.00034	0.00142	CcSEcCtD
Tranylcypromine—Tremor—Paclitaxel—kidney cancer	0.00034	0.00142	CcSEcCtD
Tranylcypromine—Insomnia—Vincristine—kidney cancer	0.000337	0.00141	CcSEcCtD
Tranylcypromine—Anorexia—Gemcitabine—kidney cancer	0.000337	0.00141	CcSEcCtD
Tranylcypromine—Vomiting—Vinblastine—kidney cancer	0.000337	0.00141	CcSEcCtD
Tranylcypromine—Dizziness—Erlotinib—kidney cancer	0.000337	0.00141	CcSEcCtD
Tranylcypromine—Vomiting—Everolimus—kidney cancer	0.000336	0.0014	CcSEcCtD
Tranylcypromine—Anaemia—Paclitaxel—kidney cancer	0.000336	0.0014	CcSEcCtD
Tranylcypromine—Paraesthesia—Vincristine—kidney cancer	0.000335	0.0014	CcSEcCtD
Tranylcypromine—Agitation—Paclitaxel—kidney cancer	0.000334	0.00139	CcSEcCtD
Tranylcypromine—Rash—Everolimus—kidney cancer	0.000333	0.00139	CcSEcCtD
Tranylcypromine—Dermatitis—Everolimus—kidney cancer	0.000333	0.00139	CcSEcCtD
Tranylcypromine—Headache—Vinblastine—kidney cancer	0.000332	0.00139	CcSEcCtD
Tranylcypromine—Headache—Everolimus—kidney cancer	0.000331	0.00138	CcSEcCtD
Tranylcypromine—Hypotension—Gemcitabine—kidney cancer	0.000331	0.00138	CcSEcCtD
Tranylcypromine—Abdominal pain—Dactinomycin—kidney cancer	0.00033	0.00138	CcSEcCtD
Tranylcypromine—Body temperature increased—Dactinomycin—kidney cancer	0.00033	0.00138	CcSEcCtD
Tranylcypromine—Asthenia—Sorafenib—kidney cancer	0.000329	0.00137	CcSEcCtD
Tranylcypromine—Syncope—Paclitaxel—kidney cancer	0.000326	0.00136	CcSEcCtD
Tranylcypromine—Leukopenia—Paclitaxel—kidney cancer	0.000325	0.00136	CcSEcCtD
Tranylcypromine—Decreased appetite—Vincristine—kidney cancer	0.000324	0.00135	CcSEcCtD
Tranylcypromine—Vomiting—Erlotinib—kidney cancer	0.000324	0.00135	CcSEcCtD
Tranylcypromine—Rash—Erlotinib—kidney cancer	0.000321	0.00134	CcSEcCtD
Tranylcypromine—Dermatitis—Erlotinib—kidney cancer	0.000321	0.00134	CcSEcCtD
Tranylcypromine—Palpitations—Paclitaxel—kidney cancer	0.000321	0.00134	CcSEcCtD
Tranylcypromine—Insomnia—Gemcitabine—kidney cancer	0.00032	0.00134	CcSEcCtD
Tranylcypromine—Headache—Erlotinib—kidney cancer	0.000319	0.00133	CcSEcCtD
Tranylcypromine—Tinnitus—Capecitabine—kidney cancer	0.000319	0.00133	CcSEcCtD
Tranylcypromine—Loss of consciousness—Paclitaxel—kidney cancer	0.000319	0.00133	CcSEcCtD
Tranylcypromine—Pain—Vincristine—kidney cancer	0.000319	0.00133	CcSEcCtD
Tranylcypromine—Constipation—Vincristine—kidney cancer	0.000319	0.00133	CcSEcCtD
Tranylcypromine—Paraesthesia—Gemcitabine—kidney cancer	0.000318	0.00133	CcSEcCtD
Tranylcypromine—Flushing—Capecitabine—kidney cancer	0.000318	0.00133	CcSEcCtD
Tranylcypromine—Asthenia—Sunitinib—kidney cancer	0.000316	0.00132	CcSEcCtD
Tranylcypromine—Nausea—Vinblastine—kidney cancer	0.000315	0.00132	CcSEcCtD
Tranylcypromine—Somnolence—Gemcitabine—kidney cancer	0.000315	0.00131	CcSEcCtD
Tranylcypromine—Nausea—Everolimus—kidney cancer	0.000314	0.00131	CcSEcCtD
Tranylcypromine—Diarrhoea—Sorafenib—kidney cancer	0.000314	0.00131	CcSEcCtD
Tranylcypromine—Hypertension—Paclitaxel—kidney cancer	0.000313	0.00131	CcSEcCtD
Tranylcypromine—Anxiety—Paclitaxel—kidney cancer	0.000308	0.00129	CcSEcCtD
Tranylcypromine—Decreased appetite—Gemcitabine—kidney cancer	0.000308	0.00129	CcSEcCtD
Tranylcypromine—Chills—Capecitabine—kidney cancer	0.000307	0.00128	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Vincristine—kidney cancer	0.000305	0.00127	CcSEcCtD
Tranylcypromine—Dizziness—Sorafenib—kidney cancer	0.000303	0.00127	CcSEcCtD
Tranylcypromine—Constipation—Gemcitabine—kidney cancer	0.000303	0.00126	CcSEcCtD
Tranylcypromine—Pain—Gemcitabine—kidney cancer	0.000303	0.00126	CcSEcCtD
Tranylcypromine—Nausea—Erlotinib—kidney cancer	0.000303	0.00126	CcSEcCtD
Tranylcypromine—Alopecia—Capecitabine—kidney cancer	0.000302	0.00126	CcSEcCtD
Tranylcypromine—Dry mouth—Paclitaxel—kidney cancer	0.000302	0.00126	CcSEcCtD
Tranylcypromine—Diarrhoea—Sunitinib—kidney cancer	0.000302	0.00126	CcSEcCtD
Tranylcypromine—Ataxia—Doxorubicin—kidney cancer	0.0003	0.00125	CcSEcCtD
Tranylcypromine—Asthenia—Dactinomycin—kidney cancer	0.0003	0.00125	CcSEcCtD
Tranylcypromine—Confusional state—Paclitaxel—kidney cancer	0.000299	0.00125	CcSEcCtD
Tranylcypromine—Oedema—Paclitaxel—kidney cancer	0.000296	0.00124	CcSEcCtD
Tranylcypromine—Abdominal pain—Vincristine—kidney cancer	0.000295	0.00123	CcSEcCtD
Tranylcypromine—Body temperature increased—Vincristine—kidney cancer	0.000295	0.00123	CcSEcCtD
Tranylcypromine—Dizziness—Sunitinib—kidney cancer	0.000292	0.00122	CcSEcCtD
Tranylcypromine—Feeling abnormal—Gemcitabine—kidney cancer	0.000292	0.00122	CcSEcCtD
Tranylcypromine—Shock—Paclitaxel—kidney cancer	0.000291	0.00122	CcSEcCtD
Tranylcypromine—Vomiting—Sorafenib—kidney cancer	0.000291	0.00122	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Paclitaxel—kidney cancer	0.00029	0.00121	CcSEcCtD
Tranylcypromine—Tachycardia—Paclitaxel—kidney cancer	0.000289	0.00121	CcSEcCtD
Tranylcypromine—Rash—Sorafenib—kidney cancer	0.000289	0.00121	CcSEcCtD
Tranylcypromine—Dermatitis—Sorafenib—kidney cancer	0.000289	0.00121	CcSEcCtD
Tranylcypromine—Headache—Sorafenib—kidney cancer	0.000287	0.0012	CcSEcCtD
Tranylcypromine—Muscle spasms—Capecitabine—kidney cancer	0.000286	0.0012	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000286	0.0012	CcSEcCtD
Tranylcypromine—Diarrhoea—Dactinomycin—kidney cancer	0.000286	0.00119	CcSEcCtD
Tranylcypromine—Anorexia—Paclitaxel—kidney cancer	0.000282	0.00118	CcSEcCtD
Tranylcypromine—Vision blurred—Capecitabine—kidney cancer	0.000281	0.00117	CcSEcCtD
Tranylcypromine—Vomiting—Sunitinib—kidney cancer	0.00028	0.00117	CcSEcCtD
Tranylcypromine—Body temperature increased—Gemcitabine—kidney cancer	0.00028	0.00117	CcSEcCtD
Tranylcypromine—Tremor—Capecitabine—kidney cancer	0.000279	0.00117	CcSEcCtD
Tranylcypromine—Rash—Sunitinib—kidney cancer	0.000278	0.00116	CcSEcCtD
Tranylcypromine—Dermatitis—Sunitinib—kidney cancer	0.000278	0.00116	CcSEcCtD
Tranylcypromine—Hypotension—Paclitaxel—kidney cancer	0.000277	0.00116	CcSEcCtD
Tranylcypromine—Headache—Sunitinib—kidney cancer	0.000276	0.00115	CcSEcCtD
Tranylcypromine—Anaemia—Capecitabine—kidney cancer	0.000275	0.00115	CcSEcCtD
Tranylcypromine—Nausea—Sorafenib—kidney cancer	0.000272	0.00114	CcSEcCtD
Tranylcypromine—Insomnia—Paclitaxel—kidney cancer	0.000268	0.00112	CcSEcCtD
Tranylcypromine—Asthenia—Vincristine—kidney cancer	0.000268	0.00112	CcSEcCtD
Tranylcypromine—Syncope—Capecitabine—kidney cancer	0.000267	0.00112	CcSEcCtD
Tranylcypromine—Leukopenia—Capecitabine—kidney cancer	0.000267	0.00111	CcSEcCtD
Tranylcypromine—Paraesthesia—Paclitaxel—kidney cancer	0.000266	0.00111	CcSEcCtD
Tranylcypromine—Vomiting—Dactinomycin—kidney cancer	0.000265	0.00111	CcSEcCtD
Tranylcypromine—Somnolence—Paclitaxel—kidney cancer	0.000263	0.0011	CcSEcCtD
Tranylcypromine—Palpitations—Capecitabine—kidney cancer	0.000263	0.0011	CcSEcCtD
Tranylcypromine—Rash—Dactinomycin—kidney cancer	0.000263	0.0011	CcSEcCtD
Tranylcypromine—Nausea—Sunitinib—kidney cancer	0.000262	0.00109	CcSEcCtD
Tranylcypromine—Loss of consciousness—Capecitabine—kidney cancer	0.000262	0.00109	CcSEcCtD
Tranylcypromine—Decreased appetite—Paclitaxel—kidney cancer	0.000258	0.00108	CcSEcCtD
Tranylcypromine—Hypertension—Capecitabine—kidney cancer	0.000257	0.00107	CcSEcCtD
Tranylcypromine—Diarrhoea—Vincristine—kidney cancer	0.000255	0.00107	CcSEcCtD
Tranylcypromine—Pollakiuria—Doxorubicin—kidney cancer	0.000255	0.00106	CcSEcCtD
Tranylcypromine—Asthenia—Gemcitabine—kidney cancer	0.000254	0.00106	CcSEcCtD
Tranylcypromine—Pain—Paclitaxel—kidney cancer	0.000253	0.00106	CcSEcCtD
Tranylcypromine—Constipation—Paclitaxel—kidney cancer	0.000253	0.00106	CcSEcCtD
Tranylcypromine—Anxiety—Capecitabine—kidney cancer	0.000253	0.00106	CcSEcCtD
Tranylcypromine—Dry mouth—Capecitabine—kidney cancer	0.000248	0.00104	CcSEcCtD
Tranylcypromine—Nausea—Dactinomycin—kidney cancer	0.000248	0.00104	CcSEcCtD
Tranylcypromine—Dizziness—Vincristine—kidney cancer	0.000247	0.00103	CcSEcCtD
Tranylcypromine—Drowsiness—Doxorubicin—kidney cancer	0.000246	0.00103	CcSEcCtD
Tranylcypromine—Confusional state—Capecitabine—kidney cancer	0.000245	0.00102	CcSEcCtD
Tranylcypromine—Feeling abnormal—Paclitaxel—kidney cancer	0.000244	0.00102	CcSEcCtD
Tranylcypromine—Oedema—Capecitabine—kidney cancer	0.000243	0.00102	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000242	0.00101	CcSEcCtD
Tranylcypromine—Diarrhoea—Gemcitabine—kidney cancer	0.000242	0.00101	CcSEcCtD
Tranylcypromine—Shock—Capecitabine—kidney cancer	0.000239	0.000999	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Capecitabine—kidney cancer	0.000238	0.000995	CcSEcCtD
Tranylcypromine—Tachycardia—Capecitabine—kidney cancer	0.000237	0.000991	CcSEcCtD
Tranylcypromine—Vomiting—Vincristine—kidney cancer	0.000237	0.000991	CcSEcCtD
Tranylcypromine—Sweating—Doxorubicin—kidney cancer	0.000236	0.000984	CcSEcCtD
Tranylcypromine—Urticaria—Paclitaxel—kidney cancer	0.000235	0.000983	CcSEcCtD
Tranylcypromine—Rash—Vincristine—kidney cancer	0.000235	0.000983	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Capecitabine—kidney cancer	0.000235	0.000982	CcSEcCtD
Tranylcypromine—Dermatitis—Vincristine—kidney cancer	0.000235	0.000982	CcSEcCtD
Tranylcypromine—Abdominal pain—Paclitaxel—kidney cancer	0.000234	0.000978	CcSEcCtD
Tranylcypromine—Body temperature increased—Paclitaxel—kidney cancer	0.000234	0.000978	CcSEcCtD
Tranylcypromine—Headache—Vincristine—kidney cancer	0.000234	0.000976	CcSEcCtD
Tranylcypromine—Anorexia—Capecitabine—kidney cancer	0.000232	0.000968	CcSEcCtD
Tranylcypromine—Agranulocytosis—Doxorubicin—kidney cancer	0.000229	0.000958	CcSEcCtD
Tranylcypromine—Hypotension—Capecitabine—kidney cancer	0.000227	0.000949	CcSEcCtD
Tranylcypromine—Vomiting—Gemcitabine—kidney cancer	0.000225	0.00094	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—kidney cancer	0.000225	0.000938	CcSEcCtD
Tranylcypromine—Rash—Gemcitabine—kidney cancer	0.000223	0.000932	CcSEcCtD
Tranylcypromine—Dermatitis—Gemcitabine—kidney cancer	0.000223	0.000931	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—kidney cancer	0.000222	0.000926	CcSEcCtD
Tranylcypromine—Headache—Gemcitabine—kidney cancer	0.000222	0.000926	CcSEcCtD
Tranylcypromine—Nausea—Vincristine—kidney cancer	0.000222	0.000926	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—kidney cancer	0.000221	0.000922	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—kidney cancer	0.000221	0.000922	CcSEcCtD
Tranylcypromine—Insomnia—Capecitabine—kidney cancer	0.00022	0.000919	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000219	0.000917	CcSEcCtD
Tranylcypromine—Paraesthesia—Capecitabine—kidney cancer	0.000218	0.000912	CcSEcCtD
Tranylcypromine—Asthenia—Paclitaxel—kidney cancer	0.000213	0.000888	CcSEcCtD
Tranylcypromine—Decreased appetite—Capecitabine—kidney cancer	0.000211	0.000883	CcSEcCtD
Tranylcypromine—Nausea—Gemcitabine—kidney cancer	0.00021	0.000878	CcSEcCtD
Tranylcypromine—Constipation—Capecitabine—kidney cancer	0.000208	0.000869	CcSEcCtD
Tranylcypromine—Pain—Capecitabine—kidney cancer	0.000208	0.000869	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—kidney cancer	0.000206	0.000859	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—kidney cancer	0.000205	0.000855	CcSEcCtD
Tranylcypromine—Diarrhoea—Paclitaxel—kidney cancer	0.000203	0.000847	CcSEcCtD
Tranylcypromine—Feeling abnormal—Capecitabine—kidney cancer	0.0002	0.000837	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000199	0.000831	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—kidney cancer	0.000198	0.000827	CcSEcCtD
Tranylcypromine—Dizziness—Paclitaxel—kidney cancer	0.000196	0.000818	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—kidney cancer	0.000195	0.000814	CcSEcCtD
Tranylcypromine—Urticaria—Capecitabine—kidney cancer	0.000193	0.000807	CcSEcCtD
Tranylcypromine—Abdominal pain—Capecitabine—kidney cancer	0.000192	0.000803	CcSEcCtD
Tranylcypromine—Body temperature increased—Capecitabine—kidney cancer	0.000192	0.000803	CcSEcCtD
Tranylcypromine—Vomiting—Paclitaxel—kidney cancer	0.000188	0.000787	CcSEcCtD
Tranylcypromine—Rash—Paclitaxel—kidney cancer	0.000187	0.00078	CcSEcCtD
Tranylcypromine—Dermatitis—Paclitaxel—kidney cancer	0.000187	0.00078	CcSEcCtD
Tranylcypromine—Headache—Paclitaxel—kidney cancer	0.000186	0.000775	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—kidney cancer	0.000185	0.000771	CcSEcCtD
Tranylcypromine—Vision blurred—Doxorubicin—kidney cancer	0.000181	0.000756	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—kidney cancer	0.000177	0.000741	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—kidney cancer	0.000176	0.000737	CcSEcCtD
Tranylcypromine—Nausea—Paclitaxel—kidney cancer	0.000176	0.000735	CcSEcCtD
Tranylcypromine—Asthenia—Capecitabine—kidney cancer	0.000174	0.000729	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—kidney cancer	0.000172	0.000719	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—kidney cancer	0.000172	0.000718	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—kidney cancer	0.00017	0.000709	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—kidney cancer	0.000169	0.000705	CcSEcCtD
Tranylcypromine—Diarrhoea—Capecitabine—kidney cancer	0.000166	0.000695	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—kidney cancer	0.000166	0.000693	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—kidney cancer	0.000163	0.000681	CcSEcCtD
Tranylcypromine—Dizziness—Capecitabine—kidney cancer	0.000161	0.000672	CcSEcCtD
Tranylcypromine—Dry mouth—Doxorubicin—kidney cancer	0.00016	0.000668	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—kidney cancer	0.000158	0.00066	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—kidney cancer	0.000157	0.000655	CcSEcCtD
Tranylcypromine—Vomiting—Capecitabine—kidney cancer	0.000155	0.000646	CcSEcCtD
Tranylcypromine—Shock—Doxorubicin—kidney cancer	0.000154	0.000644	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000153	0.000641	CcSEcCtD
Tranylcypromine—Rash—Capecitabine—kidney cancer	0.000153	0.00064	CcSEcCtD
Tranylcypromine—Dermatitis—Capecitabine—kidney cancer	0.000153	0.00064	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—kidney cancer	0.000153	0.000639	CcSEcCtD
Tranylcypromine—Headache—Capecitabine—kidney cancer	0.000152	0.000636	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000152	0.000633	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—kidney cancer	0.000149	0.000624	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—kidney cancer	0.000146	0.000612	CcSEcCtD
Tranylcypromine—Nausea—Capecitabine—kidney cancer	0.000144	0.000603	CcSEcCtD
Tranylcypromine—Insomnia—Doxorubicin—kidney cancer	0.000142	0.000592	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—kidney cancer	0.000141	0.000588	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—kidney cancer	0.000139	0.000582	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—kidney cancer	0.000136	0.000569	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—kidney cancer	0.000134	0.00056	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—kidney cancer	0.000134	0.00056	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—kidney cancer	0.000129	0.00054	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000128	0.000535	CcSEcCtD
Tranylcypromine—Urticaria—Doxorubicin—kidney cancer	0.000124	0.00052	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—kidney cancer	0.000124	0.000518	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—kidney cancer	0.000124	0.000518	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—kidney cancer	0.000112	0.00047	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—kidney cancer	0.000107	0.000448	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—kidney cancer	0.000104	0.000433	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—kidney cancer	9.96e-05	0.000416	CcSEcCtD
Tranylcypromine—Rash—Doxorubicin—kidney cancer	9.88e-05	0.000413	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—kidney cancer	9.87e-05	0.000412	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—kidney cancer	9.82e-05	0.00041	CcSEcCtD
Tranylcypromine—Nausea—Doxorubicin—kidney cancer	9.31e-05	0.000389	CcSEcCtD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.42e-05	0.000398	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.42e-05	0.000398	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PGK1—kidney cancer	3.4e-05	0.000396	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—SLC5A3—kidney cancer	3.4e-05	0.000396	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ACHE—kidney cancer	3.4e-05	0.000396	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTT1—kidney cancer	3.4e-05	0.000396	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.38e-05	0.000394	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.37e-05	0.000392	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—LDHB—kidney cancer	3.34e-05	0.000388	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.32e-05	0.000386	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PDHB—kidney cancer	3.31e-05	0.000385	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—POMC—kidney cancer	3.3e-05	0.000384	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.29e-05	0.000383	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CYP1A1—kidney cancer	3.27e-05	0.000381	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APRT—kidney cancer	3.22e-05	0.000375	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—FH—kidney cancer	3.22e-05	0.000375	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—SCARB1—kidney cancer	3.22e-05	0.000374	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPAT—kidney cancer	3.19e-05	0.000371	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GLIPR1—kidney cancer	3.19e-05	0.000371	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS1—kidney cancer	3.18e-05	0.000371	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GLIPR1—kidney cancer	3.16e-05	0.000367	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPAT—kidney cancer	3.16e-05	0.000367	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.15e-05	0.000366	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PSMD7—kidney cancer	3.12e-05	0.000363	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.12e-05	0.000363	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CCBL1—kidney cancer	3.11e-05	0.000362	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CRABP1—kidney cancer	3.11e-05	0.000362	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.09e-05	0.000359	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GPC3—kidney cancer	3.03e-05	0.000352	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ACY1—kidney cancer	3e-05	0.00035	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APRT—kidney cancer	2.96e-05	0.000345	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—FH—kidney cancer	2.96e-05	0.000345	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—BCHE—kidney cancer	2.96e-05	0.000345	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CA2—kidney cancer	2.94e-05	0.000343	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—FH—kidney cancer	2.94e-05	0.000342	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APRT—kidney cancer	2.94e-05	0.000342	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—SLC5A5—kidney cancer	2.92e-05	0.00034	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ITPR2—kidney cancer	2.89e-05	0.000337	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CA9—kidney cancer	2.89e-05	0.000337	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ALAD—kidney cancer	2.87e-05	0.000334	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.87e-05	0.000334	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—SLC2A1—kidney cancer	2.82e-05	0.000329	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.81e-05	0.000328	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.8e-05	0.000326	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GPC3—kidney cancer	2.78e-05	0.000324	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GPC3—kidney cancer	2.76e-05	0.000321	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.74e-05	0.000319	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CA2—kidney cancer	2.71e-05	0.000315	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPAT—kidney cancer	2.7e-05	0.000314	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.7e-05	0.000314	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CA2—kidney cancer	2.68e-05	0.000312	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.66e-05	0.00031	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALAD—kidney cancer	2.64e-05	0.000307	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTT1—kidney cancer	2.64e-05	0.000307	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ACHE—kidney cancer	2.64e-05	0.000307	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.64e-05	0.000307	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PGK1—kidney cancer	2.62e-05	0.000305	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.62e-05	0.000305	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALAD—kidney cancer	2.62e-05	0.000305	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.58e-05	0.0003	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—LDHB—kidney cancer	2.57e-05	0.0003	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PDHB—kidney cancer	2.55e-05	0.000297	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.55e-05	0.000297	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—POMC—kidney cancer	2.55e-05	0.000296	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.52e-05	0.000293	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APRT—kidney cancer	2.51e-05	0.000292	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—FH—kidney cancer	2.51e-05	0.000292	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—SCARB1—kidney cancer	2.5e-05	0.000291	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.5e-05	0.000291	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS1—kidney cancer	2.47e-05	0.000288	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CRABP1—kidney cancer	2.46e-05	0.000286	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.45e-05	0.000285	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—POMC—kidney cancer	2.44e-05	0.000284	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PSMD7—kidney cancer	2.42e-05	0.000282	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PGK1—kidney cancer	2.41e-05	0.000281	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.41e-05	0.000281	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CCBL1—kidney cancer	2.4e-05	0.00028	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.39e-05	0.000279	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PGK1—kidney cancer	2.39e-05	0.000279	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—LDHB—kidney cancer	2.37e-05	0.000276	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GPC3—kidney cancer	2.36e-05	0.000274	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTP1—kidney cancer	2.36e-05	0.000274	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—LDHB—kidney cancer	2.35e-05	0.000273	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—BCHE—kidney cancer	2.3e-05	0.000268	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CA2—kidney cancer	2.29e-05	0.000267	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ITPR2—kidney cancer	2.29e-05	0.000266	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—SLC5A5—kidney cancer	2.27e-05	0.000264	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALAD—kidney cancer	2.24e-05	0.00026	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CA9—kidney cancer	2.23e-05	0.00026	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ABCB1—kidney cancer	2.23e-05	0.00026	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—SLC2A1—kidney cancer	2.19e-05	0.000255	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ST3GAL2—kidney cancer	2.18e-05	0.000254	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.18e-05	0.000254	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTM1—kidney cancer	2.16e-05	0.000252	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALDH1A1—kidney cancer	2.13e-05	0.000248	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTT1—kidney cancer	2.09e-05	0.000243	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ACHE—kidney cancer	2.09e-05	0.000243	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPAT—kidney cancer	2.08e-05	0.000242	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.08e-05	0.000242	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CA9—kidney cancer	2.05e-05	0.000239	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP1A1—kidney cancer	2.05e-05	0.000239	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PGK1—kidney cancer	2.04e-05	0.000238	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC5A3—kidney cancer	2.04e-05	0.000238	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CA9—kidney cancer	2.03e-05	0.000237	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—LDHB—kidney cancer	2.01e-05	0.000233	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.99e-05	0.000231	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—SCARB1—kidney cancer	1.97e-05	0.00023	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS1—kidney cancer	1.95e-05	0.000227	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTGS2—kidney cancer	1.94e-05	0.000226	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APRT—kidney cancer	1.94e-05	0.000225	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—FH—kidney cancer	1.94e-05	0.000225	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PSMD7—kidney cancer	1.92e-05	0.000223	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CRABP1—kidney cancer	1.9e-05	0.000221	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTP1—kidney cancer	1.83e-05	0.000213	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GPC3—kidney cancer	1.82e-05	0.000212	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—BCHE—kidney cancer	1.82e-05	0.000211	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.79e-05	0.000209	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CA2—kidney cancer	1.77e-05	0.000206	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ITPR2—kidney cancer	1.76e-05	0.000205	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CRABP1—kidney cancer	1.75e-05	0.000203	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CA9—kidney cancer	1.74e-05	0.000202	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.73e-05	0.000202	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ABCB1—kidney cancer	1.73e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CRABP1—kidney cancer	1.73e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALAD—kidney cancer	1.73e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.7e-05	0.000198	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTEN—kidney cancer	1.7e-05	0.000197	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.68e-05	0.000196	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTM1—kidney cancer	1.68e-05	0.000196	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.65e-05	0.000192	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.63e-05	0.000189	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.62e-05	0.000189	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ACHE—kidney cancer	1.61e-05	0.000187	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTT1—kidney cancer	1.61e-05	0.000187	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ITPR2—kidney cancer	1.61e-05	0.000187	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP1A1—kidney cancer	1.59e-05	0.000185	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PGK1—kidney cancer	1.58e-05	0.000184	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.58e-05	0.000184	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—LDHB—kidney cancer	1.55e-05	0.00018	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—POMC—kidney cancer	1.53e-05	0.000178	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SCARB1—kidney cancer	1.52e-05	0.000177	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS1—kidney cancer	1.51e-05	0.000175	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.48e-05	0.000173	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ACHE—kidney cancer	1.48e-05	0.000172	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTT1—kidney cancer	1.48e-05	0.000172	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CRABP1—kidney cancer	1.48e-05	0.000172	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PSMD7—kidney cancer	1.48e-05	0.000172	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ACHE—kidney cancer	1.47e-05	0.000171	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTT1—kidney cancer	1.47e-05	0.000171	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTP1—kidney cancer	1.45e-05	0.000168	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—BCHE—kidney cancer	1.4e-05	0.000163	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SCARB1—kidney cancer	1.4e-05	0.000163	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SCARB1—kidney cancer	1.39e-05	0.000162	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS1—kidney cancer	1.39e-05	0.000161	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.38e-05	0.000161	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ITPR2—kidney cancer	1.37e-05	0.00016	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS1—kidney cancer	1.37e-05	0.00016	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ABCB1—kidney cancer	1.37e-05	0.000159	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PSMD7—kidney cancer	1.36e-05	0.000158	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PSMD7—kidney cancer	1.35e-05	0.000157	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CA9—kidney cancer	1.34e-05	0.000156	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.34e-05	0.000156	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTM1—kidney cancer	1.33e-05	0.000155	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.3e-05	0.000151	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—BCHE—kidney cancer	1.29e-05	0.00015	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—BCHE—kidney cancer	1.28e-05	0.000149	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.27e-05	0.000148	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.27e-05	0.000147	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.26e-05	0.000147	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.26e-05	0.000147	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ACHE—kidney cancer	1.25e-05	0.000146	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTT1—kidney cancer	1.25e-05	0.000146	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.23e-05	0.000143	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS2—kidney cancer	1.22e-05	0.000142	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.22e-05	0.000142	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PIK3CA—kidney cancer	1.2e-05	0.000139	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—POMC—kidney cancer	1.19e-05	0.000138	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SCARB1—kidney cancer	1.19e-05	0.000138	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.18e-05	0.000138	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS1—kidney cancer	1.17e-05	0.000137	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PSMD7—kidney cancer	1.15e-05	0.000134	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CRABP1—kidney cancer	1.14e-05	0.000133	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.13e-05	0.000132	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTP1—kidney cancer	1.12e-05	0.00013	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—BCHE—kidney cancer	1.09e-05	0.000127	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC5A5—kidney cancer	1.08e-05	0.000126	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTEN—kidney cancer	1.06e-05	0.000124	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ITPR2—kidney cancer	1.06e-05	0.000123	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ABCB1—kidney cancer	1.06e-05	0.000123	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC2A1—kidney cancer	1.04e-05	0.000121	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.03e-05	0.00012	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTP1—kidney cancer	1.03e-05	0.000119	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTM1—kidney cancer	1.02e-05	0.000119	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTP1—kidney cancer	1.02e-05	0.000118	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.01e-05	0.000118	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP1A1—kidney cancer	9.71e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ABCB1—kidney cancer	9.71e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTT1—kidney cancer	9.67e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ACHE—kidney cancer	9.67e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ABCB1—kidney cancer	9.62e-06	0.000112	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS2—kidney cancer	9.47e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTM1—kidney cancer	9.42e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—POMC—kidney cancer	9.39e-06	0.000109	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTM1—kidney cancer	9.34e-06	0.000109	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SCARB1—kidney cancer	9.16e-06	0.000107	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS1—kidney cancer	9.06e-06	0.000105	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP1A1—kidney cancer	8.93e-06	0.000104	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PSMD7—kidney cancer	8.89e-06	0.000103	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP1A1—kidney cancer	8.86e-06	0.000103	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.81e-06	0.000103	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTP1—kidney cancer	8.69e-06	0.000101	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—BCHE—kidney cancer	8.43e-06	9.81e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC5A5—kidney cancer	8.32e-06	9.69e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTEN—kidney cancer	8.26e-06	9.62e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ABCB1—kidney cancer	8.22e-06	9.57e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC2A1—kidney cancer	8.04e-06	9.36e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTM1—kidney cancer	7.98e-06	9.29e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.98e-06	9.29e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP1A1—kidney cancer	7.57e-06	8.81e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CA—kidney cancer	7.51e-06	8.74e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS2—kidney cancer	7.49e-06	8.71e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.28e-06	8.47e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—POMC—kidney cancer	7.24e-06	8.43e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTP1—kidney cancer	6.71e-06	7.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—POMC—kidney cancer	6.66e-06	7.75e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—POMC—kidney cancer	6.6e-06	7.69e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTEN—kidney cancer	6.53e-06	7.6e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCB1—kidney cancer	6.35e-06	7.39e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.22e-06	7.24e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTM1—kidney cancer	6.16e-06	7.17e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.84e-06	6.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CA—kidney cancer	5.83e-06	6.78e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS2—kidney cancer	5.78e-06	6.72e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—POMC—kidney cancer	5.64e-06	6.57e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS2—kidney cancer	5.31e-06	6.18e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS2—kidney cancer	5.27e-06	6.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTEN—kidney cancer	5.04e-06	5.86e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTEN—kidney cancer	4.63e-06	5.39e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CA—kidney cancer	4.61e-06	5.36e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTEN—kidney cancer	4.59e-06	5.35e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS2—kidney cancer	4.5e-06	5.24e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—POMC—kidney cancer	4.36e-06	5.07e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTEN—kidney cancer	3.93e-06	4.57e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.55e-06	4.14e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS2—kidney cancer	3.47e-06	4.04e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CA—kidney cancer	3.27e-06	3.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.24e-06	3.77e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTEN—kidney cancer	3.03e-06	3.53e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.77e-06	3.22e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.14e-06	2.49e-05	CbGpPWpGaD
